• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与MCD型相比,EZB型弥漫性大B细胞淋巴瘤细胞系具有更强的迁移能力。

EZB-type diffuse large B-cell lymphoma cell lines have superior migration capabilities compared to MCD-type.

作者信息

Sherif Marwa, Schäfer Hendrik, Scharf Sonja, van Oostendorp Vivienne, Sadeghi Shoreh Deli Aresu, Loth Andreas G, Piel Matthieu, Hansmann Martin-Leo, Oellerich Thomas, Fend Falko, Quintanilla-Martinez Leticia, Hartmann Sylvia

机构信息

Dr. Senckenberg Institute of Pathology, Goethe University Frankfurt am Main, Frankfurt am Main, Germany.

Department of Otolaryngology, Head and Neck Surgery, University Hospital Frankfurt, Frankfurt am Main, Germany.

出版信息

Br J Haematol. 2024 Dec;205(6):2327-2337. doi: 10.1111/bjh.19778. Epub 2024 Oct 2.

DOI:10.1111/bjh.19778
PMID:39355919
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11637725/
Abstract

Diffuse large B-cell lymphoma (DLBCL) represents the most prevalent aggressive B-cell lymphoma. The group is heterogeneous and the outcome is variable. A variety of approaches have been employed with the objective of improving the stratification of DLBCL patients according to their prognosis, based on the cell of origin. Recently, distinct genetic subtypes of DLBCL have been identified. Given the importance of cell migration in immune cells, the objective of this study was to ascertain whether different genetic subtypes of DLBCL exhibit disparate migration abilities. MCD- and EZB-type DLBCL cell lines were subjected to testing to ascertain their basal velocity in straight microchannels and their ability to overcome tight constrictions of 2 μm. The EZB-type cell lines showed superior basal migration velocity and constriction passage time, and a similar trend was observed in live cell imaging of native human DLBCL tissue. In addition, MCD-type DLBCL exhibited significantly elevated levels of nuclear lamin A/C, which is responsible for the stiffness of the nuclear envelope and could thus explain the disparate migration behaviours observed among these subtypes. Our study suggests that different genetic subtypes of DLBCL may not only influence the outcome after therapy but also the motility of the tumour cells.

摘要

弥漫性大B细胞淋巴瘤(DLBCL)是最常见的侵袭性B细胞淋巴瘤。该组具有异质性,预后也各不相同。为了根据起源细胞改善DLBCL患者的预后分层,人们采用了多种方法。最近,已鉴定出DLBCL的不同基因亚型。鉴于细胞迁移在免疫细胞中的重要性,本研究的目的是确定DLBCL的不同基因亚型是否表现出不同的迁移能力。对MCD型和EZB型DLBCL细胞系进行测试,以确定它们在直微通道中的基础速度以及克服2μm紧密收缩的能力。EZB型细胞系表现出更高的基础迁移速度和收缩通过时间,在天然人类DLBCL组织的活细胞成像中也观察到了类似趋势。此外,MCD型DLBCL的核纤层蛋白A/C水平显著升高,核纤层蛋白A/C负责核膜的硬度,因此可以解释这些亚型之间观察到的不同迁移行为。我们的研究表明,DLBCL的不同基因亚型不仅可能影响治疗后的结果,还可能影响肿瘤细胞的运动性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7096/11637725/50394b2d32ee/BJH-205-2327-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7096/11637725/90c944a1a222/BJH-205-2327-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7096/11637725/d03372d8eb07/BJH-205-2327-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7096/11637725/16b0e7a70874/BJH-205-2327-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7096/11637725/008fc886d1e3/BJH-205-2327-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7096/11637725/50394b2d32ee/BJH-205-2327-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7096/11637725/90c944a1a222/BJH-205-2327-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7096/11637725/d03372d8eb07/BJH-205-2327-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7096/11637725/16b0e7a70874/BJH-205-2327-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7096/11637725/008fc886d1e3/BJH-205-2327-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7096/11637725/50394b2d32ee/BJH-205-2327-g005.jpg

相似文献

1
EZB-type diffuse large B-cell lymphoma cell lines have superior migration capabilities compared to MCD-type.与MCD型相比,EZB型弥漫性大B细胞淋巴瘤细胞系具有更强的迁移能力。
Br J Haematol. 2024 Dec;205(6):2327-2337. doi: 10.1111/bjh.19778. Epub 2024 Oct 2.
2
Genetic subtyping by Whole Exome Sequencing across Diffuse Large B Cell Lymphoma and Plasmablastic Lymphoma.通过全外显子测序对弥漫性大B细胞淋巴瘤和浆母细胞淋巴瘤进行基因分型。
PLoS One. 2025 Mar 11;20(3):e0318689. doi: 10.1371/journal.pone.0318689. eCollection 2025.
3
Primary bone diffuse large B-cell lymphoma (PB-DLBCL): a distinct extranodal lymphoma of germinal centre origin, with a common EZB-like mutational profile and good prognosis.原发性骨弥漫性大 B 细胞淋巴瘤(PB-DLBCL):一种独特的生发中心起源的结外淋巴瘤,具有常见的 EZB 样突变特征和良好的预后。
Histopathology. 2024 Feb;84(3):525-538. doi: 10.1111/his.15096. Epub 2023 Nov 15.
4
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.弥漫性大B细胞淋巴瘤的遗传学与发病机制
N Engl J Med. 2018 Apr 12;378(15):1396-1407. doi: 10.1056/NEJMoa1801445.
5
Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.弥漫性大 B 细胞淋巴瘤的遗传亚型简化算法。
Signal Transduct Target Ther. 2023 Apr 10;8(1):145. doi: 10.1038/s41392-023-01358-y.
6
Dyslipidemia in diffuse large B-cell lymphoma based on the genetic subtypes: a single-center study of 259 Chinese patients.基于基因亚型的弥漫性大B细胞淋巴瘤血脂异常:一项对259例中国患者的单中心研究。
Front Oncol. 2023 Jun 9;13:1172623. doi: 10.3389/fonc.2023.1172623. eCollection 2023.
7
Diffuse large B-cell lymphoma.弥漫性大 B 细胞淋巴瘤。
Pathology. 2018 Jan;50(1):74-87. doi: 10.1016/j.pathol.2017.09.006. Epub 2017 Nov 20.
8
Molecular Characterization and Genetic Subclassification Comparison of Diffuse Large B-Cell Lymphoma: Real-Life Experience with 74 Cases.弥漫性大 B 细胞淋巴瘤的分子特征和遗传亚型比较:74 例真实世界经验。
Pathobiology. 2024;91(4):245-253. doi: 10.1159/000535938. Epub 2023 Dec 21.
9
The prognostic significance of MYC/BCL2 double expression in DLBCL in the genetic classification era.在基因分类时代,MYC/BCL2双表达在弥漫性大B细胞淋巴瘤中的预后意义。
Cancer Sci. 2025 Jan;116(1):257-270. doi: 10.1111/cas.16377. Epub 2024 Nov 4.
10
Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma.免疫微环境的遗传亚型和表型特征以及 MYC/BCL2 双表达揭示弥漫性大 B 细胞淋巴瘤的异质性。
Clin Cancer Res. 2022 Mar 1;28(5):972-983. doi: 10.1158/1078-0432.CCR-21-2949.

本文引用的文献

1
HK2 contributes to the proliferation, migration, and invasion of diffuse large B-cell lymphoma cells by enhancing the ERK1/2 signaling pathway.己糖激酶2通过增强ERK1/2信号通路促进弥漫性大B细胞淋巴瘤细胞的增殖、迁移和侵袭。
Open Life Sci. 2023 Oct 14;18(1):20220726. doi: 10.1515/biol-2022-0726. eCollection 2023.
2
Glycoproteomics Identifies Plexin-B3 as a Targetable Cell Surface Protein Required for the Growth and Invasion of Triple-Negative Breast Cancer Cells.糖蛋白质组学鉴定出 Plexin-B3 是三阴性乳腺癌细胞生长和侵袭所必需的可靶向细胞表面蛋白。
J Proteome Res. 2022 Sep 2;21(9):2224-2236. doi: 10.1021/acs.jproteome.2c00332. Epub 2022 Aug 18.
3
PLAGL2 Promotes the Proliferation and Migration of Diffuse Large B-cell Lymphoma Cells via Wnt/β-catenin Pathway.
PLAGL2 通过 Wnt/β-catenin 通路促进弥漫性大 B 细胞淋巴瘤细胞的增殖和迁移。
Ann Clin Lab Sci. 2022 May;52(3):359-366.
4
T-cell-derived Hodgkin lymphoma has motility characteristics intermediate between Hodgkin and anaplastic large cell lymphoma.T 细胞来源的霍奇金淋巴瘤具有介于霍奇金淋巴瘤和间变大细胞淋巴瘤之间的运动特征。
J Cell Mol Med. 2022 Jun;26(12):3495-3505. doi: 10.1111/jcmm.17389. Epub 2022 May 19.
5
LncRNA SNHG5 can Regulate the Proliferation and Migration of Diffuse Large B Cell Lymphoma Progression via Targeting miR-181-5p/XIAP.长链非编码RNA SNHG5可通过靶向miR-181-5p/XIAP调控弥漫性大B细胞淋巴瘤进展中的增殖和迁移。
J Cancer. 2022 Jan 1;13(3):784-792. doi: 10.7150/jca.60521. eCollection 2022.
6
Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas.霍奇金淋巴瘤和非霍奇金淋巴瘤中4D细胞相互作用的全景
Cancers (Basel). 2021 Oct 17;13(20):5208. doi: 10.3390/cancers13205208.
7
Targeting the tumor microenvironment in B-cell lymphoma: challenges and opportunities.靶向 B 细胞淋巴瘤的肿瘤微环境:挑战与机遇。
J Hematol Oncol. 2021 Aug 17;14(1):125. doi: 10.1186/s13045-021-01134-x.
8
LncRNA PCAT1 enhances cell proliferation, migration and invasion by miR-508-3p/NFIB axis in diffuse large B-cell lymphoma.长链非编码 RNA PCAT1 通过 miR-508-3p/NFIB 轴增强弥漫性大 B 细胞淋巴瘤中的细胞增殖、迁移和侵袭。
Eur Rev Med Pharmacol Sci. 2021 Mar;25(6):2567-2576. doi: 10.26355/eurrev_202103_25420.
9
FBN1 promotes DLBCL cell migration by activating the Wnt/β-catenin signaling pathway and regulating TIMP1.FBN1通过激活Wnt/β-连环蛋白信号通路并调节TIMP1来促进弥漫性大B细胞淋巴瘤(DLBCL)细胞迁移。
Am J Transl Res. 2020 Nov 15;12(11):7340-7353. eCollection 2020.
10
DEPTOR is a microRNA-155 target regulating migration and cytokine production in diffuse large B-cell lymphoma cells.DEPTOR 是 microRNA-155 的靶标,调节弥漫性大 B 细胞淋巴瘤细胞的迁移和细胞因子产生。
Exp Hematol. 2020 Aug;88:56-67.e2. doi: 10.1016/j.exphem.2020.07.005. Epub 2020 Jul 20.